CURy Best Abstract Award
Sponsored by
G. Gakis, D. Schilling, M. Renninger, K.D. Sievert, A. Stenzl
Eberhard-Karls University, Department of Urology, Tubingen, Germany
SUBSTRATIFICATION IN NODE-NEGATIVE PT2 BLADDER CANCER IS AN INDEPENDENT PREDICTOR FOR RECURRENCE-FREE SURVIVAL: A CONTEMPORARY SERIES
G.-L. Hsu, C.-H. Hsieh, Y.-P. Huang, M.-H. Tsai, K.-L. Chen, C.-H. Chang, H.-C. Wu
Microsurgical Potency Reconstruction and Research Center, Department of Urology, China Medical University, Taichung; Buddhist Tzu Chi General Hospital, Taipei Branch & Department of Physiology & Department of Anatomy, China Medical University, China
PENILE VEINS ARE THE DETERMINING CONTRIBUTOR FOR ERECTION: THE HEMODYNAMIC EVIDENCE FROM THE STUDY IN DEFROSTED HUMAN CADAVERS
H. Sasaki, J. Miki, T. Kimura, Y. Yamamoto, K. Miki, S. Egawa
Jikei University School of Medicine, Tokyo, Japan
LATERAL VIEW DISSECTION OF THE PROSTATO-URETHRAL JUNCTION TO REDUCE APICAL MARGIN POSITIVITY IN LAPAROSCOPIC RADICAL PROSTATECTOMY
K. Wadhwa, S. Devenish, S.R. Keoghane, B.H. Walmsley
South Coast Stone Centre, Queen Alexandra Hospital, Portsmouth, UK
CAN RADIATION EXPOSURE DURING UPPER TRACT ENDOSCOPY BE REDUCED?
D. Lamm, H. Akaza, A. Boehle, J. Palou, M. Brausi, R. Buckley, R. Persad, M. Colombel, M. O’Donnell
Department of Surgery, University of Arizona; BCG Oncology, Phoenix, Arizona, USA; Department of Urology, University of Tsukuba, Tsukuba, Japan; Department of Urology, HELIOS Agnes Karll Hospital, Bad Schwartau, Germany; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, AUSL Modena Estense and B Ramazzini Hospitals, Modena, Italy; Department of Urology, North York General Hospital, Toronto, Ontario, Canada; Department of Urology/Surgery, Bristol Royal Infirmary & Bristol Urological Institute, Bristol, United Kingdom; Department of Urology, Claude Bernard University, Hôpital Edouard Herriot, Lyon, France; Department of Urology, University of Iowa, Iowa City, Iowa, USA
3 WEEK MAINTENANCE BCG IS NECESSARY FOR OPTIMAL PREVENTION OF RECURRENCE, PROGRESSION, METASTASIS AND MORTALITY IN TA, T1 AND IN SITU BLADDER CANCER
D. Karamanolakis, I. Roxanis, S. Pomplun, C.T. Brown, D. Sharma, C. Kouriefs, P.C.R. Grange
Department of Urology and Department of Histopathology, King's CH, London, UK
Department of Experimental Physiology, Medical School, University of Athens; Urology Clinic, "THRIASSION" General Hospital, Elefsina; Urology Clinic, "METAXA" General Hospital, Pireaus; Endo/OncoResearch Laboratory, Medical Diagnostic Center, Ampelokipi, Athens & Department of Hygiene and Epidemiology, Medical School, University of Athens, Goudi-Athens, Greece
3-DIMENTIONAL PATHOLOGICAL MAPPING SATURATION BIOPSIES OF THE PROSTATE: OUR INITIAL EXPERIENCE
R. Oliveira, M. Guimaraes, R. Pinto, P. Silva, F. Pina, F. Cruz
Hospital Sao Joao, Department of Urology, Porto & Hospital da ordem do Carmo, Department of Urology, Porto, Portugal
LONG-TERM ASSESSMENT OF THE BONE-ANCHORED PERINEAL MALE SLING FOR POST-PROSTATECTOMY INCONTINENCE
R.O.P. Draga, H.J. Noordmans, M.C.M. Grimbergen, T.M.T.W. Lock, R.J.L.H. Bosch
Department of Urology, Medical Technology and Clinical Physics, University Medical Center, Utrecht, The Netherlands
THE FEASIBILITY OF REAL-TIME BLADDER NAVIGATION
J. Tack, J. Wyndaele, M.E. Egermark, G. Ligozio
Catholic University Leuven, University Hospital Antwerp, Belgium
Novartis Pharma AG, Basel, Switzerland
Novartis Pharmaceuticals Corporation, NJ, USA
IMPACT OF CONSTIPATION ASSOCIATED WITH DARIFENACIN USE IN THE TREATMENT OF OVERACTIVE BLADDER
M. Margreiter, A. Farr, N. Swietek, H.C. Klingler, M. Marberger
Department of Urology, Medical University of Vienna, Vienna, Austria
URETHRAL AUGMENTATION IN PATIENTS UNDERGOING ARTIFICIAL URINARY SPHINCTER REVISION
WebStudio.co.il